Hakan Çam

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

ORCID: 0000-0002-5057-9757

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma”.

Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma

Neuro-Oncology(2025)10.1093/neuonc/noaf195

N/A

0.270DataRank · unranked

4 citations

Daniel Kreatsoulas, Hakan Çam, Chelsea Bolyard, Yuzhou Chang, Jay K. Mandula +16 more

Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence

Journal of Hematology & Oncology(2022)10.1186/s13045-022-01298-0

N/A

0DataRank · unranked

68 citations

Chelsea Bolyard, Bill X. Wu, Hakan Çam, Pierre Giglio, Zihai Li +1 more